(Q44296688)

1 December 2017

title

Evolution of microbial resistance to fluoroquinolones at a tertiary hospital (English)

1 reference

1 December 2017

Queipo Zaragozá JA

1

1 reference

1 December 2017

Budía Alba A

2

1 reference

1 December 2017

Jiménez Martí MJ

3

1 reference

1 December 2017

Mascaros García E

4

1 reference

1 December 2017

Gómez-Ferrer Lozano A

5

1 reference

1 December 2017

Gobernado Serrano M

6

1 reference

1 December 2017

Jiménez Cruz JF

7

1 reference

1 December 2017

publication date

1 May 2000

1 reference

Actas Urológicas Españolas

1 December 2017

published in

1 reference

1 December 2017

volume

24

1 reference

1 December 2017

issue

5

1 reference

1 December 2017

page(s)

381-387

1 reference

Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2800%2972467-3

7 January 2021

DNA Gyrase and the Supercoiling of DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2800%2972467-3

7 January 2021

Mechanism of inhibition of DNA gyrase by analogues of nalidixic acid: the target of the drugs is DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2800%2972467-3

7 January 2021

The SOS regulatory system of Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2800%2972467-3

7 January 2021

Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2800%2972467-3

7 January 2021

Analysis by PCR and direct DNA sequencing of gyrA mutations associated with fluoroquinolone resistance in Enterococcus faecalis.

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2800%2972467-3

7 January 2021

Mutations in the gyrA gene of a highly fluoroquinolone-resistant clinical isolate of Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2800%2972467-3

7 January 2021

Cloning and characterization of a DNA gyrase A gene from Escherichia coli that confers clinical resistance to 4-quinolones.

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2800%2972467-3

7 January 2021

Mechanisms of quinolone resistance in clinical isolates: accumulation of sparfloxacin and of fluoroquinolones of various hydrophobicity, and analysis of membrane composition.

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2800%2972467-3

7 January 2021

Mechanisms of quinolone resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2800%2972467-3

7 January 2021

Role of protein D2 and lipopolysaccharide in diffusion of quinolones through the outer membrane of Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2800%2972467-3

7 January 2021

Development of quinolone-imipenem cross resistance in Pseudomonas aeruginosa during exposure to ciprofloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2800%2972467-3

7 January 2021

Ten-year survey of quinolone resistance in Escherichia coli causing urinary tract infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0210-4806%2800%2972467-3

7 January 2021

10.1016/S0210-4806(00)72467-3

Identifiers

DOI

1 reference

1 December 2017

1 reference